| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |